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522Objectives: Continuous flow in the Fontan circulation results in impairment of pulmonary artery endothelial
function, increased pulmonary arterial resistance, and, potentially, late failure of Fontan circulation. We inves-
tigated the mechanisms of vascular remodeling and altered vascular reactivity associated with chronic privation
of pulsatility on pulmonary vasculature.
Methods: A total of 30 pigs were evenly distributed in 3 groups: 10 underwent a sham procedure (group I) and
20 underwent a cavopulmonary shunt between the superior vena cava and right pulmonary artery—10 with com-
plete ligation of the proximal right pulmonary artery (group II, nonpulsatile) and 10 with partial ligation (group
III, micropulsatile). At 3 months postoperatively, the in vivo hemodynamics, in vitro vasomotricity (concentra-
tion response curves on pulmonary artery isolated rings), and endothelial nitric oxide synthase protein level were
assessed. A comparison between group and between the right and left lung in each group was performed.
Results: Group II developed right pulmonary hypertension and increased right pulmonary resistance. Endothe-
lial function was altered in group II, as reflected by a decrease in the vasodilation response to acetylcholine
and ionophoric calcium but preservation of the nonendothelial-dependent response to sodium nitroprusside.
Group III micropulsatility attenuated pulmonary hypertension but did not prevent impairment of the
endothelial-dependant relaxation response. Right lung Western blotting revealed decreased endothelial nitric
oxide synthase in group II (0.941  0.149 vs sham 1.536  0.222, P ¼ .045) that was preserved in group III
(1.275  0.236, P ¼ .39).
Conclusions: In a chronic model of unilateral cavopulmonary shunt, pulsatility loss resulted in an altered
endothelial-dependant vasorelaxation response of the pulmonary arteries. Micropulsatility limited the effects
of pulsatility loss. These results are of importance for potential therapies against pulmonary hypertension in
the nonpulsatile Fontan circulation, by retaining accessory pulmonary flow or pharmaceutical modulation of
nonendothelial-dependant pulmonary vasorelaxation. (J Thorac Cardiovasc Surg 2013;146:522-9)The Fontan operation1 has become the procedure of choice
in the treatment of patients with a single anatomic or func-
tional ventricle. The procedure places the systemic and pul-
monary circulation in series, with the systemic circulation
driven effectively by the single ventricle, and most of the
pulmonary blood flow, which comes directly from the
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diastolic function of the single ventricle. It results in a pul-
monary circulation very different from physiologic condi-
tions, known as the ‘‘Fontan circulation.’’e Department of Cardiothoracic Surgery,a Ho^pital Louis Pradel, Hospices
de Lyon, Claude Bernard Lyon I University, Faculte de Medecine–
atoire de Physiologie, Lyon, France; Department of Pediatric Cardiac
ry,b New York-Presbyterian/Morgan Stanley Children’s Hospital, Columbia
rsity, New York, NY; Laboratoire de Chirurgie Experimentale,c Universite
XI Ho^pital Marie Lannelongue, Le Plessis-Robinson, France; and Department
iatric Cardiac Surgery,d Jacques Cartier Hospital, Massy, France.
res: Authors have nothing to disclose with regard to commercial support.
d for publication Sept 20, 2012; accepted for publication Nov 9, 2012;
ble ahead of print Dec 10, 2012.
for reprints: Roland Henaine, MD, Department of Cardiac Surgery C,
ologic Hospital Louis Pradel, Ave du Doyen Lepine, Lyon 69394 France
il: roland.henaine@chu-lyon.fr).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.11.031
The Journal of Thoracic and Cardiovascular SurgThe Fontan operation has been shown to benefit patients
with a single functioning ventricle and low pulmonary resis-
tance.2 Its outcome and the risk of Fontan failure are highly
dependent on several risk factors such as ventricular func-
tion, pulmonary artery size and valve regurgitation; how-
ever, pulmonary vascular resistance (PVR) plays a key
role. Even a slight increase in PVR can result in failure of
the procedure. More and more evidence has shown that en-
dothelial dysfunction (ie, the inability to react appropriately
to various stimuli), is 1 of the root causes of Fontan failure
in these patients. The Fontan physiology exerts a consider-
able effect on the pulmonary circulation, characterized by
increased pulmonary vascular impedance. The lack of pul-
satile blood flow has major effects on endothelial function,3
vascular recruitment, and lung vessel growth, which in turn
influence PVR.4 The long-term consequences of these ab-
normalities are becoming of increasing concern as the pop-
ulation of survivors increases.
Several disadvantages regarding nonpulsatile pulmonary
flow have been reported, in both global and microvascular
pulmonary circulation.5-7 The vasodilatory potential of
pulsatile flow and wall shear stress are well recognized in
both pulmonary8 and systemic vascular beds.9,10 Previousery c September 2013
Abbreviations and Acronyms
EC50 ¼ 50% of the maximal response
eNOS ¼ endothelial nitric oxide synthase
Emax ¼ maximal response
NO ¼ nitric oxide
PA ¼ pulmonary artery
PAP ¼ pulmonary artery pressure
PVP ¼ pulmonary vein pressure
PVR ¼ pulmonary vascular resistance
SVC ¼ superior vena cava
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pulmonary circulation have revealed an increase in PVR.
Numerous experiments of the effect of pulsatility on the
pulmonary endothelium have been performed in vitro, in
nonphysiologic conditions, using an isolated lung prepara-
tion. The influence of the autonomous nervous system and
other vasoactive hormonal agents was therefore excluded.
In contrast, in vivo long-term experimental studies are not
possible, because animal models of Fontan circulation do
not exist.
Although the vascular morphology is well described, the
mechanisms of vascular remodeling and altered vascular
reactivity associated with chronic privation of pulsatility
on pulmonary vasculature remain incompletely understood.
Despite the extensive analyses, the physiologic changes
of pulmonary vasculature after cavopulmonary shunt have
not been thoroughly investigated, and the underlying path-
ogenesis of steady flow-induced pulmonary hypertension of
Fontan circulation remains poorly understood.
In the present study, we investigated the influence of flow
pulsatility on the hemodynamics and vasomotricity of the
pulmonary vasculature in a chronic porcine model of unilat-
eral cavopulmonary shunt, using the contralateral lung as
the control.
We hypothesized that preserving some antegrade pulsa-
tility would maintain endothelial function and prevent
steady flow-induced pulmonary hypertension.
Using in vivo hemodynamics measurements and in vitro
vasoreactivity, we examined the effects of pulsatility, non-
pulsatility, and micropulsatility blood flow on the pulmo-
nary vascular bed.
We also determined the expression of endothelial nitric
oxide (NO) synthase (eNOS) protein under these different
pulsatility regimens.
METHODS
Surgical Protocol
Animal preparation. A total of 30 large white pigs weighing
20  2 kg were used in the present study. All the pigs received humane
care in compliance with the ‘‘Principles of Laboratory Animal Care,’’ for-
mulated by the National Society for Medical Research, and the ‘‘Guide forThe Journal of Thoracic and Cathe Care and Use of Laboratory Animals,’’ published by the National Insti-
tutes of Health (NIH publication no. 85-23, revised 1996).
Anesthesia was induced with intramuscular ketamine (10 mg/kg) and
atropine sulfate (0.2 mg/kg) and maintained with intravenous pentobarbital
(10 mg/kg bolus; continuous infusion, 0.1 mg/kg/min).
The pigs were paralyzed with pancuronium (0.3 mg/kg). After endotra-
cheal intubation, intermittent positive-pressure ventilation was provided
(MMS RET 107 ventilator; MMS, Pau, France) at a tidal volume of
10 mL/kg, respiratory rate of 18 cycles/min, fraction of inspired oxygen
of 0.5. The body temperature was kept constant at 37C.
Surgical preparation. After midline sternotomy, the superior vena
cava (SVC) was dissected, and the azygos and right mammary vein were
ligated to allow full mobilization of the SVC. The right pulmonary artery
(PA) was dissected, up to the superior upper lobe branch. The baseline
hemodynamic values were recorded before additional manipulation: direct
measurement of the aortic pressure, PA pressure (PAP; trunk, right branch),
SVC pressure, and left and right pulmonary vein pressures (PVPs) was
done; and the blood flow rate (with ultrasonic peritubular transit time
flow probes and the T106/T206 Animal Research Flowmeter [Transonic
System, Ithaca, NY]) of the aorta and PA trunk and PA right branch were
measured. A dose of 100 IU/kg heparin was administered. For group I
(sham group), no procedure was performed. In group II (nonpulsatile),
the SVC was disconnected from the right atrium and anastomosed end-
to-side to the right PA, with ligation of the origin of the right PA. In group
III (micropulsatile), a similar SVC-to-right PA anastomosis was performed,
but the right PAwas banded at its origin using a 3-mm Hegar dilator. The
hemodynamic data were also collected after the procedure.
The total PVR (mm Hg/min/L) was calculated by dividing the pressure
decrease in mm Hg between the PA and left atrium (Ppa  Pla) in mm Hg
by the flow Q_ in L/min: PVR ¼ (Ppa  Pla)/Q_.
To avoid postoperative occlusion of the anastomosis, the pigs were anti-
coagulated with fractionated heparin until the terminal study.
The terminal study was performed at 3 months. With the pigs under
general anesthesia, the angiographic catheter was placed in the right
PA through the right jugular vein, under fluoroscopic guidance. Correct
patency of the anastomosis was controlled. Next, fourth intercostal space
left thoracotomy was performed; the hemodynamic data were collected.
Subsequently, right thoracotomy was performed, and the respective hemo-
dynamic data were collected. After heparinization, the pigs were killed by
exsanguination under deep anesthesia. The lungs were removed for histo-
logic sampling.
Histologic Examination
The right and left inferior lobe fragments were harvested, and the
tissues were fixed in 10% buffered formalin and imbedded in paraffin. Sec-
tions (4 mm thick) were cut for light microscopic examination and stained
with hematoxylin-phloxin-saffron and orcein-picroindigo-carmine.
In Vitro Pulmonary Vasomotricity
Four intrapulmonary arterial segments were isolated for each pig and
each lung. Carefully preserving the integrity of endothelium and removing
any adipose tissue, the vessels were cut into 3-mm-long and 4-mm external
diameter rings. The samples were placed in tissue bath containing Krebs-
Henseleit bicarbonate buffer (composition 118.3 mM NaCl, 25 mM
NaHCO3, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2.5 mM
CaCl2, 0.03 mM ethylenediaminetetraacetic acid, and 11.1 mM glucose)
at 37C and bubbled continuously with 95% oxygen and 5% carbon diox-
ide. The rings were then mounted onto stainless steel supports, suspended
in 10-mL tissue baths, and connected to force displacement transducers
(LB-5; Showa-Sokki, Tokyo, Japan) linked to an amplifier (emka Technol-
ogies, Falls Church, Va) and a computerized acquisition system to record
any changes in force generated by the preparation. The resting tension
was adjusted to 1 g and corresponded to the optimal length for tension
development in the porcine PA. The rings were then equilibrated forrdiovascular Surgery c Volume 146, Number 3 523
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replaced every 10 minutes.
After incubation with indomethacin (105 M) for 60 minutes, a concen-
tration–response curve to phenylephrine (109-3.104 M) was obtained.
The rings were then rinsed, and the developed force was allowed to return
to baseline. The rings were then precontracted with phenylephrine to gen-
erate 1 g of developed force. Once a stable contraction was obtained, dif-
ferent pharmacologic protocols were performed.
Cumulative doses of acetylcholine (109-104 M), calcium ionophore
(1010-3.107 M), sodium nitroprusside (109-104 M) were added to
the bath to assess the changes in endothelium-dependent relaxation. These
rings were again washed and allowed to equilibrate to baseline levels.
The procedure was repeated with a single dose (105 M) of sodium
nitroprusside, an endothelium-independent vasodilator.
In addition to the change in force, the responses were assessed by deter-
mining the concentration that produced 50% of the maximal response
(EC50), extrapolated from a plot of log concentration versus the percentage
of maximal response.
The maximal response (Emax) represents the maximal intensity of the
contraction or relaxation to an agonist. The contractile response to phenyl-
ephrine is expressed in absolute values (g), and the maximal relaxation to
acetylcholine and calcium ionophore are expressed as percentages of the
phenylephrine-induced precontraction, with 0% indicating no relaxation
and 100% indicating a relaxation equal to that of the precontraction.
Western Blot Analysis
Four 2- to 3-g samples from each right lung were harvested, snap-frozen
in liquid nitrogen, and stored at80C. The tissuewas homogenized on ice
using an Ultrathurax homogenizer (Kinematica, Lucerne, Switzerland) in
1 mL of CHAPS lysis buffer. The extracts were clarified by centrifugation
(490g for 15 minutes at 4C).
The supernatant was separated on 7% sodium dodecyl sulfate-
polyacrilamide gel and electrophoretically transferred to polyvinylidene
difluoride membranes (Immobilon transfer membrane, IPVH00010; EMD
Millipore, Billerica, Mass). The membranes were blocked at room tempera-
turewith 5%bovine serumalbumin (A4503-100G;SigmaAldrich,StLouis,
Mo) in Tris-buffered saline containing 0.1% Tween 20. The membranes
were incubated with mouse polyclonal anti-eNOS (1:1000, N30020; BD
Transduction Laboratories, BD Biosciences, Franklin Lakes, NJ) diluted
on blocking solution (1 hour at room temperature). The membranes wereTABLE 1. Hemodynamic, baseline, and terminal data in 3 groups
Variable
Group I
Baseline 3 mo
Pigs (n) 10 10
Weight (kg) 20  1 40  8
AoP (mm Hg) 52.8  12.4 82.3  25.1 56
PAPr (mm Hg) 9.0  2.8 11.1  0.6 9
PAPl (mm Hg) 10.9  1.8 12.6  1.3 10
PVPr (mm Hg) 3.9  1.4x 7.1  0.2 4
PVPl (mm Hg) 7.4  1.5
Ao outflow 1.90  0.13 2.34  0.58 2.
SVC outflow 0.55  0.06 NA 0.
PAr outflow 1.27  0.05z 1.70  0.58z 1.
PAl outflow 0.69  0.03z 1.48  0.18z 0.
PVR right lung (mm Hg/min/L) 5.47  1.82z 2.36  0.45 4.
PVR left lung, mm Hg/min/L 10.16  3.20z 3.56  0.82 8.
Data presented as mean  standard deviation. AoP,Mean aortic pressure; PAl, left pulmon
PAPr, mean right pulmonary arterial pressure; PVPl, mean left pulmonary vein pressure; P
aortic; SVC, superior vena cava;NA, not available. *Significant difference to group I. ySigni
right and left vein pressure were identical and equal to left atrial pressure at baseline, wit
524 The Journal of Thoracic and Cardiovascular Surgwashed 2 times for 5 minutes and 1 time for 15 minutes with Tris-buffered
saline containing 0.1% Tween 20 before they were hybridized with
1:10,000 dilution of anti-mouse horseradish peroxidase antibody (no.
401215, Calbiochem, EMD Millipore; 1 hour at room temperature). After
the 2 times 5-minute and 1 time 15-minutewashes, the bandswerevisualized
with chemiluminescence on radiographic film (Kodak BioMax MS Film;
Eastman Kodak Company, Rochester, NY) using an ECL Kit (Amersham,
Arlington Heights, Ill).
A lung extract from a sham piglet was included on each gel as an inter-
nal control. Each membrane was probed for the protein of interest and then
reprobed for b-actin. Each densitometric value (Gene Tools; Syngene,
Cambridge, Mass) was divided by its b-actin control to obtain a relative
value for the eNOS protein levels. The relative values were averaged and
then corrected using a factor defined as the relative protein level of the in-
ternal control obtained from that particular blot divided by the relative pro-
tein level of the internal control from the reference membrane of the same
protein of interest. The results are reported as the proportion of the internal
control that equaled 1.
Statistical Analysis
Data are expressed as themean standard deviation. Statistical analysis
(for hemodynamic and vasoreactivity studies) was performed for compar-
ison between groups at each point, between each point among same group,
and, finally, between the right and left lung of the same pig (intraindividual
control). Each pig served as its own control.
The datawere analyzedwith the software package, Statview IV (Abacus
Concepts, Berkeley, Calif). Hemodynamic comparisons were performed
using a paired Student t test. The vasoreactivity comparisons were per-
formed with 2-way analysis of variance followed by Fisher’s exact test or
a chi-square test for the between-group comparisons. The Western blot
comparisons between groups were made using the unpaired Student t test.RESULTS
Hemodynamic Data
The baseline characteristics and hemodynamic data were
similar between the groups (Table 1).
At 3 months, the patency of anastomosis was correct
in all the pigs. The right PAP was significantly increasedGroup II Group III
Baseline 3 mo Baseline 3 mo
10 10 10 10
22  3 54  7 19  3 46  3
.6  7.4 57.3  5.8 54  3.1 70  19.2
.6  3.8 26.7  1.3*,y,z 8.8  2.7 14.2  0.8*,z
.4  1.9 19.4  4.7*,z 11.8  1.3 17.9  4.4*,z
.6  1.3x 14.1  3.0*,y,z 3.8  2.2x 7.4  2.6
8.6  0.4z 8.8  0.7
10  0.47 2.57  0.45 2.00  0.22 2.32  0.24
80  0.36 NA 0.52  0.21 NA
32  0.27z 1.82  0.04z 1.30  0.15z 1.68  0.36z
71  0.14z 2.62  0.52*,y,z 0.70  0.08z 2.16  0.37*,z
69  2.13z 6.92  1.83*,y,z 6.23  1.37z 4.20  1.36*
70  3.73z 3.92  1.40z 11.58  2.40z 4.09  1.83
ary artery; PAr, right pulmonary artery; PAPl, mean left pulmonary arterial pressure;
VPr, mean right pulmonary vein pressure; PVR, pulmonary vascular resistance; Ao,
ficant difference to group III. zSignificant difference to contralateral side. xPulmonary
h left atrial pressure presented.
ery c September 2013
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group III (14.2  0.8 mm Hg, P < .0001) compared
with sham-operated controls (group I; 11.1  0.6 mm
Hg), with significant difference between groups II and
III (P ¼ .0005). The right PVP (14.1  3 mm Hg) was
significantly increased in group II relative to groups I
and III, but group III demonstrated no statistical variation
compared with group I (sham). The PVR in the right
lung was significantly greater in group II (6.92 
1.83 mm Hg/min/L) than in group I (2.36  0.45 mm
Hg/min/L; P ¼ .001) or group III (4.20  1.36 mm
Hg/min/L, P ¼ .001). The right PVR was significantly
elevated in group III compared with group I (4.20 
1.36 vs 2.36  0.45 mm Hg/min/L, P ¼ .001) but to
a lesser extent than in group II.
Finally, comparing the right and left lung of each pig,
the PVR was greater in the right lung for group II
(P ¼ .001) and was not statistically different from that of
group I (P ¼ .12) or group III (P ¼ .88).
For the left lung, the left PAP was significantly increased
in group II (19.4  4.7 mm Hg, P ¼ .019) and group III
(17.9  4.4 mm Hg, P ¼ .05) relative to group I, but with
no difference between groups II and III. No statistically sig-
nificant difference was found among the 3 groups for PVP
and PVR.
For the intraindividual comparison, no difference was
found in sham group I, except for the PVR (2.36  0.45
for the right lung vs 3.56  0.82 mm Hg/min/L for the
left lung, P ¼ .001). For group II, the right PAP was signif-
icantly greater than the left PAP (26.7  1.3 vs 19.4  4.7
mm Hg, P¼ .0003), the right PVP was significantly greater
than the left PVP (14.1  3.0 vs 8.6  0.4 mm Hg,
P ¼ .0004), and the PVR was significantly greater in the
right lung than in the left lung (6.92  1.83 vs
3.92  1.40 mm Hg/min/L, P ¼ .001).
For group III, no statistically significant increase was
found between the right and left lung for PAP, PVP, or
PVR. The PAP was even lower in the right lung (14.2 
0.8 vs 17.9  4.4 mm Hg, P ¼ .003).FIGURE 1. Example of lung sections ipsilateral to A, B, cavopulmonary anast
tative of groups II and III) after cavopulmonary anastomosis, stained with hemato
demonstrate hyperplasia of venous wall under pleura in Figure A, along bronchia
lung demonstrating normal histologic findings with normal venous wall thickn
The Journal of Thoracic and CaHistologic Findings
No histologic changes were found in lung extract from
the sham group I or group II and group III left lungs.
The right lung specimens from group II demonstrated
alterations unlike those in groups I and III. Venous hyper-
plasia was noted, located along the bronchial axes, between
the alveolar lobules, and under the pleura. The venous wall
thickness was enlarged, with muscular hyperplasia of the
media (Figure 1).
No histologic changes were found in the arterial walls.
Vasoreactivity
No difference in vasoreactivity was found between the
right and left lungs in group I.
Vasoconstrictor Response of Pulmonary Rings
In group II (Figure 2, A), maximal tension response
developed by phenylephrine was significantly greater in
the right PA than in the left PA (3.75  0.37 vs
1.95  0.35 mg, P ¼ .001), and the EC50 concentration
was greater for the right PA than for the left PA (8.30
107  1.9 107 vs 5.6 107  1.8 107 M, P ¼ .323). In
group III (Figure 2, D), no significant difference was found
in the Emax or EC50 between the right and left PAs. A com-
parison of the right PAs from all 3 groups revealed no sig-
nificant differences among the groups (Figure 3, A).
Vasodilator Responses in Pulmonary Rings
In the phenylephrine-preconstricted pulmonary rings,
vasorelaxation was depressed in the group II right PA com-
pared to the left PA, using acetylcholine (Emax, 49.9% 
7.2% vs 62.8%  6.2%, P ¼ .187; EC50, 1.9 107  5.0
108 vs 1.0 107  4.3 108 M, P ¼ .21; Figure 2, B) or
calcium ionophore (Emax, 49.6%  6.4% vs 75.3% 
6.2%, P ¼ .07; EC50, 3.9 107  3.9 108 vs 3.3
107  3.8 108 M, P ¼ .262; Figure 2, C), but without
reaching statistical significance. In group III (Figure 2,
E,F), no significant difference was found in the Emax
and EC50 between the right and left PAs.omosis and C, control lung obtained from same pig at 3 months (represen-
xylin-phloxin-saffron (magnification325; scale bar, 500 mm).Arrowheads
l axes and between alveolar lobules in Figure B of shunted lung. C, Control
ess.
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FIGURE 2. Dose-dependent responses of group II (nonpulsatile) right and left pulmonary artery (RPA and LPA, respectively) rings to cumulative addition
of A, phenylephrine, B, acetylcholine, and C, calcium ionophore. Dose-dependent responses of group III (micropulsatile) RPA and LPA rings to cumulative
addition of D, phenylephrine, E, acetylcholine, and F, calcium ionophore. A, D, Data presented as mean standard deviation of developed tension in grams
for contraction. B, C, E, F, Data presented as mean standard deviation of percentage of dilatation relative to phenylephrine-induced preconstriction level
for relaxation. RPA of group II demonstrated significantly different contraction and reduced relaxation (nonsignificant) relative to LPA. A, Phenylephrine-
induced (109-3.104 M) contraction in PA rings. Two-way analysis of variance revealed that RPA rings exhibited greater contraction to phenylephrine than
LPA rings (Emax, P ¼ .001; EC50, P ¼ .323). B, Acetylcholine-induced (109-104 M) relaxation in phenylephrine-preconstricted PA rings. Despite re-
duced RPA ring relaxation, no significant difference was found (Emax, P ¼ .187; EC50, P ¼ .210). C, Calcium ionophore-induced (1010-3.107 M) re-
laxation in phenylephrine-preconstricted PA rings. Two-way analysis of variance revealed that RPA rings exhibited blunted relaxation responses to calcium
ionophore compared with responses from left lung (Emax, P¼ .07; EC50, P¼ .262). RPA of group III demonstrated restored similar level of contraction and
relaxation, relative to LPA. D, Phenylephrine-induced (109-3.104 M) contraction in PA rings. Two-way analysis of variance revealed that restored pul-
satility abolished abnormal right pulmonary response with no difference in contraction to phenylephrine between RPA and LPA rings (Emax, P ¼ .715;
EC50, P ¼ .08). E, Acetylcholine-induced (109-104 M) relaxation in phenylephrine-preconstricted PA rings. Two-way analysis of variance revealed
that restored pulsatility abolished abnormal right pulmonary response, with no difference in relaxation to acetylcholine between RPA and LPA rings
(Emax, P¼ .495; EC50, P¼ .233). F, Calcium ionophore-induced (1010-3.107 M) relaxation in phenylephrine-preconstricted PA rings. Two-way analysis
of variance revealed that restored pulsatility abolished abnormal right pulmonary response, with no difference in relaxation to calcium ionophore between
RPA and LPA rings (Emax, P ¼ .796; EC50, P ¼ .879).
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nitroprusside between the PAs (Emax in left and right
PAs, group I, 115%  19% vs 113%  19%; group II,
108%  18% vs 115%  18%; group III, 97%  11%
vs 101%  11%, respectively).
Interindividual Comparison of Vasoreactivity
A comparison of the right PAs from groups I, II, and
III revealed no significant differences among the groups
with acetylcholine (Figure 3, B) but significantly depressed
vasorelaxation (Figure 3, C) was noted in group II (Emax,
49.6%  6.4%, P ¼ .0003; EC50, 3.9 107  3.9 108
M, P ¼ .001) and group III (Emax, 44.6%  7.3%,
P ¼ .002; EC50, 4.2 107  4.3 108 M, P ¼ .003) right
PAs with calcium ionophore compared with group I526 The Journal of Thoracic and Cardiovascular Surg(Emax, 76.8%  6.7%; EC50, 2.4 107  2.9 108 M).
No difference was demonstrated between group II and III
right PA vasorelaxation to calcium ionophore.
Immunoblot Analysis
Immunoblot analyses of lung homogenates revealed that
eNOS protein content was different among the groups
(Figure 4). eNOS protein content was significantly lower
in group II than in group I (0.941  0.149 vs 1.536 
0.222, P ¼ .045). However, group III demonstrated no sig-
nificant decrease in eNOS content (1.275 0.236, P¼ .39).
DISCUSSION
The results from the present study have indicate that, in
a chronic porcine model of unilateral cavopulmonary shunt,ery c September 2013
FIGURE 3. Dose-dependent responses of group I (sham), group II (nonpulsatile), and group III (micropulsatile) right pulmonary artery (PA) rings to
cumulative addition of phenylephrine, acetylcholine, calcium ionophore, and nitroprusside. In right PA, no difference in contraction was found
among 3 groups, but significantly reduced dilatation response was found in groups II and III, relative to sham group I. A, Phenylephrine-induced
(109-3.104 M) contraction in PA rings. Two-way analysis of variance revealed contractile responses of right PA rings were similar among groups.
B, Acetylcholine-induced (109-104 M) relaxation in phenylephrine-preconstricted PA rings. Despite reduced relaxation in groups II and III compared
with group I, no significant difference was found (groups II and III compared with group I, Emax, P ¼ .333 and P ¼ .334, respectively). C, Calcium
ionophore-induced (1010-3.107 M) relaxation in phenylephrine-preconstricted PA rings. Two-way analysis of variance revealed that group II and III
right PA rings exhibited blunted relaxation responses to calcium ionophore compared with responses of sham group I (groups II and III compared with
group I, Emax, P ¼ .002 and P ¼ .0003, EC50, P ¼ .003 and P ¼ .001, respectively). No significant difference was found in relaxation responses between
groups II and III.
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and PVR. Nonpulsatile flow decreased the endothelial-
dependent vasorelaxation response of the PAs. Finally,
expression of eNOS was depressed in the nonpulsatile cir-
culation lungs.
To the best of our knowledge, we are the first to study, in
a chronic animal model, the hemodynamics and vasomotor
function of the pulmonary vasculature exposed to non-
pulsatile blood flow. The right pulmonary endothelium is
subjected to continuous flow and the left lung receives pul-
satile flow under physiologic conditions. Thus, each pig
could act as its own control.
The hemodynamic consequence of nonpulsatile flow and
thus the loss of shear stress in the right lung of group II (non-
pulsatile) was a significant increase in right PAP compared
with that of the left lung. The PVR followed the same
course. For group III, partial antegrade pulsatile flow re-
sulted in limitation of pulmonary hypertension, because
the right PAP, even if significantly greater than that in the
sham group, was significantly lower than that in group II
and also lower than the left PAP in group III.
From a functional standpoint, pulsatility modulation also
resulted in significant changes in pulmonary vasoreactivity.
In the present study, we, for the first time, have character-
ized the vasoreactivity consequences of in vivo chronic pul-
satility loss on pulmonary vasculature. In group II, the loss
of pulsatility resulted in a significant decrease in the vasodi-
lator response to acetylcholine and calcium inophore. In
group III, antegrade pulsatile flow abolished the differences
between the right and left lung vasodilator response. How-
ever, when considering the vasodilator response of the right
lung of the 3 groups, both groups II and III demonstrated anThe Journal of Thoracic and Caimpaired response compared with sham group I, reflecting
the loss of pulsatility in group II and, to a lower extent,
in group III. Numerous experimental studies11,12 using
NO antagonists (N-methyl-L-arginine or methylene blue)
demonstrated that the response to acetylcholine was
endothelial dependent and used NO as the mediator. The
findings were also corroborated in clinical studies.13,14
Pulsatility influences the hemodynamics by acting on
endothelial function. In a clinical report on patients with a
bidirectional cavopulmonary shunt, acetylcholine-induced
vasorelaxation (endothelium-dependent vasorelaxation)
was significantly attenuated, but nitroglycerin (exogenous
NO donor and, thus, endothelium-nondependent vasorelax-
ation) was well preserved.3 Our data have corroborated
these findings, because acetylcholine relaxation of the right
lung was altered, but the nitroprusside response was pre-
served. These results suggest that Fontan circulation, by
the loss of pulsatility, is responsible for endothelial dysfunc-
tion, and the PA smooth muscle relaxation response is main-
tained. The precise mechanism of acetylcholine response
attenuation remains to be explored. In vitro studies have
demonstrated that shear stress loss resulted in lower tran-
scription of fibroblast and platelet-derived growth factors15
and of eNOS.16 Flow pulsatility has been demonstrated to
be a powerful stimulus for NO release.17
In contrast to the acetylcholine and calcium inophore re-
sponse, the vasodilator response to nitroprusside was pre-
served in all groups and on both sides in each group.
Nonendothelium-dependent vasorelaxation was not altered
by the cavopulmonary bypass procedure, regardless of
group or lung side. One of the main contributors to late
failure of the Fontan circulation is the increase in PVR.rdiovascular Surgery c Volume 146, Number 3 527
FIGURE 4. Immunoblot analysis for endothelial nitric oxide synthase
(eNOS) protein in lung tissue from 3 groups. Top, Representative immuno-
blot from protein extracts prepared from lung tissue of pig from indicated
group separated on 7.5% sodium dodecyl sulfate-polyacrylamide gel, elec-
trophoretically transferred to Hybond membranes, and analyzed using
a specific antiserum raised against eNOS. Bottom, Summary data from
10 pigs/group; densitometric values for eNOS protein normalized to b-ac-
tin protein for eNOS protein/b-actin protein. Data presented as mean 
standard deviation, normalized. eNOS protein/b-actin protein decreased
by 39% in nonpulsatile (group II, P ¼ .045) and 17% in micropulsatility
(group III, P ¼ .39).
Congenital Heart Disease Henaine et al
C
H
DBecause of the maintained response to nitroprusside in
nonpulsatile or low-pulsatility circulations, the use of exog-
enous NO agents might impede the long-term PVR increase
in Fontan patients.
The restoration of partial pulmonary pulsatility in group
III, to prevent the effects of Fontan circulation, resulted in
limitation of pulmonary hypertension. These results suggest
that some residual antegrade pulsatile flowmight play a pro-
tective role on nonpulsatile flow-induced endothelial dys-
function. However, such a protective role was not verified
in our vasomotricity study. In the clinical field, despite
initially controversial, the utility of a maintained residual
antegrade flow, after cavopulmonary shunt, has been
advocated by some investigators.18-20
To further determine the molecular mechanisms underly-
ing endothelial functional abnormalities, we investigated
the protein expression of eNOS in the remodeled vascular
wall.528 The Journal of Thoracic and Cardiovascular SurgPatients with failing Fontan circulation have been shown
to overexpress eNOS relative to normal controls and
patients with good surgical outcomes, possibly related to
endothelial dysfunction.21 However, in these patients, in-
creased shear stress is caused by abnormal pulmonary blood
flow, and polycythemia might cause endothelial dysfunc-
tion, with overstimulation of the NO pathway to maintain
low pulmonary arterial pressure. eNOS is upregulated in
shunt-induced pulmonary hypertension in lambs, in rats ex-
posed to hypoxia, and in polycythemic rats.22-24 In contrast,
in adult patients with pulmonary hypertension, eNOS
expression is reduced.25
We found that protein expression of eNOS was signifi-
cantly decreased in the nonpulsatile right lung of group II
and restored in the micropulsatile group III. This finding
is in line with our observation that endothelial-dependent
vasorelaxation is altered in group II, indicating that pulmo-
nary hypertension is likely due to endothelial dysfunction.
Because NO produces vasodilation and inhibits smooth
muscle cell mitogenesis, restored NO production, which
was induced bymicropulsatility,might represent a therapeu-
tic response to minimize the PVR in the setting of Fontan
circulation.CONCLUSIONS
The results of the present study have indicated that, in
a chronic porcine model of unilateral cavopulmonary shunt,
the lack of pulsatility results in unilateral elevation of PAP
and PVR. Nonpulsatile flow decreased the endothelial-
dependent vasorelaxation response of PAs. Using Western
blot analysis, we found that eNOS expression was de-
pressed in the nonpulsatile circulation lungs.
Because nonendothelial-dependent vasorelaxation was
maintained, endothelial dysfunction could be counter-
balanced. Therefore, nonendothelial-dependent relaxing
agents might represent a potential therapy for failing Fontan
circulation with an elevated PAP. Finally, because pulsatil-
ity is an important modulator of pulmonary vascular tone,
we demonstrated that micropulsatility limited the effects
of pulsatility loss. Our observation supports the importance
of maintaining accessory pulmonary blood flow in patients
with a bidirectional cavopulmonary shunt, from the stand-
point of pulmonary endothelial function.
We thank Dr Pascal Chiari for his critical appraisal of our
report and constructive comments.References
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